Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Loutit

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Infection and Immunity|November 1, 1995
Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cellsH J Batterman, J A Peek, J S Loutit, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Infection and Immunity|November 1, 1995
Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cellsH J Batterman, J A Peek, J S Loutit, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
Pageof 2